EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Mind-skin Interface: Depression Prevalence, Comorbidities and Treatment Outcomes in Patients with Psoriasis

Jayashree Basavaraju, Chandramohan Kudligi, Veena Ullas Nair, Meghana Patil, Varsha Muchal Prakash, Tejaswini Mukundraj, Pradeep Muthusami, Sahana Mahendra

Malaysian Journal of Dermatology · 2026

DOI: 10.4103/mjd.mjd_29_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malaysian Journal of Dermatology, 2026. Verfasst von Jayashree Basavaraju und 7 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is a chronic inflammatory dermatosis associated with substantial psychological morbidity. Indian data on depression in psoriasis remain limited, and the impact of depressive symptoms on treatment outcomes is inadequately studied.

Objectives

To estimate the prevalence of depression amongst patients with psoriasis attending a tertiary-care dermatology outpatient department, to validate depression screening using a structured psychiatric interview and to evaluate associations with clinical characteristics, comorbidities and treatment outcomes.

Methods

This hospital-based cross-sectional study with a 12-week follow-up included 70 adult patients with clinically diagnosed psoriasis. Depression was screened using the Patient Health Questionnaire-9 (PHQ-9) and validated in a randomly selected subset using the Mini International Neuropsychiatric Interview (MINI). Disease severity was assessed using the Psoriasis Area and Severity Index (PASI). Medical comorbidities were systematically recorded and treatment response was evaluated at follow-up.

Results

Depression was identified in 29 patients, yielding a prevalence of 41.4% (95% confidence interval: 29.8%–53.8%). Psychiatric validation demonstrated 89% concordance between PHQ-9 and MINI diagnoses (κ =0.78, P < 0.001). Depression severity showed no significant correlation with baseline PASI scores. Patients with depression had significantly poorer treatment response at 12 weeks, with lower mean PASI improvement and reduced PASI-75 response rates compared to non-depressed patients ( P < 0.05).

Conclusions

Depression affects over two-fifths of Indian patients with psoriasis and is associated with suboptimal treatment outcomes independent of disease severity. Routine depression screening and integrated dermatology–psychiatry care are the essential components of comprehensive psoriasis management.

Zitieren

APA

Basavaraju, J., Kudligi, C., Nair, V. U., Patil, M., Prakash, V. M., Mukundraj, T., Muthusami, P., & Mahendra, S. (2026). The Mind-skin Interface: Depression Prevalence, Comorbidities and Treatment Outcomes in Patients with Psoriasis. Malaysian Journal of Dermatology. https://doi.org/10.4103/mjd.mjd_29_25

Vancouver

Basavaraju J, Kudligi C, Nair VU, Patil M, Prakash VM, Mukundraj T, et al. The Mind-skin Interface: Depression Prevalence, Comorbidities and Treatment Outcomes in Patients with Psoriasis. Malaysian Journal of Dermatology. 2026. doi:10.4103/mjd.mjd_29_25

BibTeX
@article{Basavaraju2026,
  author = {Basavaraju, Jayashree and Kudligi, Chandramohan and Nair, Veena Ullas and Patil, Meghana and Prakash, Varsha Muchal and Mukundraj, Tejaswini and Muthusami, Pradeep and Mahendra, Sahana},
  title = {The Mind-skin Interface: Depression Prevalence, Comorbidities and Treatment Outcomes in Patients with Psoriasis},
  journal = {Malaysian Journal of Dermatology},
  year = {2026},
  doi = {10.4103/mjd.mjd_29_25}
}
Kostenlos starten →